90% of clinical trials will meet their enrollment goals if their original timelines are doubled. WCG breaks down the barriers to ramping up and meeting patient…
Passage Bio reeled in $115.5 million, which will support the development of five programs aimed at treating rare monogenic central nervous system diseases.